Sex differences in adult depression treatment outcome: An umbrella review of systematic reviews and meta-analyses

Major depressive disorder is common and burdensome, with a higher prevalence in women and documented sex differences in treatment response across medicine. However, whether sex differences in adult depression treatment outcomes are consistently reported and synthesized remains unclear. This study aims to synthesize evidence on sex differences in adult depression treatment outcomes and to assess the quality of reviews reporting these differences. It is a secondary analysis of a Campbell Collaboration Evidence and Gap Map (EGM). It is not prospectively registered. PRIOR guidance for overviews of reviews was consulted. We screened 9,475 database records and 995 EGM records; 1,397 full-text reports were assessed, and 48 systematic reviews met inclusion criteria (e.g., reported sex-disaggregated treatment outcomes). We extracted intervention, outcome, and analytical data, assessed methodological quality with AMSTAR-2, and synthesized findings narratively. Among included reviews, 13 (27.1%; 95% CI: 16.6–41.0) found significant sex differences, all with small effect sizes. Pharmacological interventions (selective serotonin reuptake inhibitors, venlafaxine) tended to favor women, psychotherapy (cognitive behavioral therapy, mindfulness) tended to favor men, and complementary and alternative treatments showed variable effects. Over half (52%, 25/48; 95% CI: 38.3–65.5) were critically low quality; 81% (39/48; 95% CI: 68.1–89.8) were low or critically low quality. Sex differences in depression treatment response are underreported. Preliminary trends of female benefit for pharmacotherapy and male benefit for psychotherapy rest on weak evidence. Routine sex-disaggregated reporting and high-quality sex-stratified research are needed. Limitations include restriction to English- and Chinese-language publications, potential overlap of primary studies, and no formal GRADE assessment.

Authors

Publication Details

Journal
Health Psychology Research
Published
2026-11-18
DOI
https://doi.org/10.36922/hpr026360220
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Sex differences in adult depression treatment outcome: An umbrella review of systematic reviews and meta-analyses

Jiahui Li, Howard White, 郭丽萍, Yicheng Qian et al.
Health Psychology Research
Treatment of Major Depression
article

Sex differences in adult depression treatment outcome: An umbrella review of systematic reviews and meta-analyses

Jiahui Li, Howard White, 郭丽萍, Yicheng Qian, Zhipeng Wei
article en

Abstract

Major depressive disorder is common and burdensome, with a higher prevalence in women and documented sex differences in treatment response across medicine. However, whether sex differences in adult depression treatment outcomes are consistently reported and synthesized remains unclear. This study aims to synthesize evidence on sex differences in adult depression treatment outcomes and to assess the quality of reviews reporting these differences. It is a secondary analysis of a Campbell Collaboration Evidence and Gap Map (EGM). It is not prospectively registered. PRIOR guidance for overviews of reviews was consulted. We screened 9,475 database records and 995 EGM records; 1,397 full-text reports were assessed, and 48 systematic reviews met inclusion criteria (e.g., reported sex-disaggregated treatment outcomes). We extracted intervention, outcome, and analytical data, assessed methodological quality with AMSTAR-2, and synthesized findings narratively. Among included reviews, 13 (27.1%; 95% CI: 16.6–41.0) found significant sex differences, all with small effect sizes. Pharmacological interventions (selective serotonin reuptake inhibitors, venlafaxine) tended to favor women, psychotherapy (cognitive behavioral therapy, mindfulness) tended to favor men, and complementary and alternative treatments showed variable effects. Over half (52%, 25/48; 95% CI: 38.3–65.5) were critically low quality; 81% (39/48; 95% CI: 68.1–89.8) were low or critically low quality. Sex differences in depression treatment response are underreported. Preliminary trends of female benefit for pharmacotherapy and male benefit for psychotherapy rest on weak evidence. Routine sex-disaggregated reporting and high-quality sex-stratified research are needed. Limitations include restriction to English- and Chinese-language publications, potential overlap of primary studies, and no formal GRADE assessment.

Health Psychology ResearchVol. 0(0)
Treatment of Major Depression
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon